Integrative Cancer Therapies
Share

Integrative Cancer Therapies

2015 Impact Factor: 1.706
2015 Ranking: 172/213 in Oncology | 8/24 in Integrative & Complementary Medicine
2016 Release of Journal Citation Reports, Source: 2015 Web of Science Data

EDITOR
Keith I. Block, MD University of Illinois at Chicago, Institute for Integrative Cancer Care, USA

eISSN: 1552695X| ISSN: 15347354|Current volume: 15|Current issue: 2 Frequency: Bi-monthly

As of January 2016, Integrative Cancer Therapies will become a Gold open access publication publishing under a Creative Commons license and requiring no subscription to access.

 
ICT is the first journal to spearhead and focus on a new and growing movement in cancer treatment. The journal emphasizes scientific understanding of alternative medicine and traditional medicine therapies, and their responsible integration with conventional health care. Integrative care includes therapeutic interventions in diet, lifestyle, exercise, stress care, and nutritional supplements, as well as experimental vaccines, chrono-chemotherapy, and other advanced treatments. Contributors are leading oncologists, researchers, nurses, and health-care professionals.

The journal presents scientifically rigorous original research, case studies, current literature reviews, educational roundtables, and commentary on key topics such as:

is the first journal to spearhead and focus on a new and growing movement in cancer treatment. The journal emphasizes scientific understanding of alternative medicine and traditional medicine therapies, and their responsible integration with conventional health care. Integrative care includes therapeutic interventions in diet, lifestyle, exercise, stress care, and nutritional supplements, as well as experimental vaccines, chrono-chemotherapy, and other advanced treatments. Contributors are leading oncologists, researchers, nurses, and health-care professionals.The journal presents scientifically rigorous original research, case studies, current literature reviews, educational roundtables, and commentary on key topics such as:
  • Treatment strategies
  • Evaluations of current therapies
  • Models for integrating complementary and conventional treatment in clinical practice
  • Interventions from alternative and traditional medicine
  • Implementing quality-of-life assessment and counseling in the clinical setting
  • Cancer rehabilitation during and following cancer treatments
  • Potential interactions of cancer chemotherapy drugs with frequently used dietary supplements
  • Implementing integrative cancer care strategies into oncology practice
  • Relevant molecular mechanisms and biology behind integrative approaches
  • Impact of timing of chemotherapy administration on toxicity, response, and outcome

This journal is a member of the Committee on Publication Ethics (COPE)

 

Integrative Cancer Therapies focuses on a new and growing movement in cancer treatment. The journal emphasizes scientific understanding of alternative medicine and traditional medicine therapies, and their responsible integration with conventional health care. Integrative care includes therapeutic interventions in diet, lifestyle, exercise, stress care, and nutritional supplements, as well as experimental vaccines, chrono-chemotherapy, and other advanced treatments. The journal presents scientifically rigorous original research, case studies, current literature reviews, educational roundtables, and commentary on key topics such as: treatment strategies, evaluations of current therapies, models for integrating complementary and conventional treatment in clinical practice, interventions from alternative and traditional medicine, implementing quality-of-life assessment and counseling in the clinical setting, cancer rehabilitation during and following cancer treatments, potential interactions of cancer chemotherapy drugs with frequently used dietary supplements, implementing integrative cancer care strategies into oncology practice, relevant molecular mechanisms and biology behind integrative approaches, impact of timing of chemotherapy administration on toxicity, response, and outcome by leading oncologists, researchers, and health-care professionals. Three unique features of this publication are: Integrative Grand Rounds - insightful case studies from all viewpoints of case management plus commentary from the editors. Point/Counterpoint -- lively discussions of controversial issues such as the interaction of antioxidants supplements and cancer chemotherapy or the effects of soy in treating breast cancer Patient's Perspective- authoritative analysis of new treatments being actively used by patients. This journal will be of particular interest to: medical, surgical, and radiation oncologists; clinical specialists frequently concerned with cancer such as urologists, gynecologists and women's health specialists; oncology and medical nurses; chiropractors; dietitians; pharmacists; and sophisticated lay people.

Associate Editors
Penny Block, PhD Block Center for Integrative Cancer Treatment
Elizabeth Krause, PharmD Chicago, Illinois, USA
Gail Mahady, PhD University of Illinois, USA
Peying Yang, PhD MD Anderson Cancer Center, University of Texas, USA
Managing Editor
Charlotte Gyllenhaal, PhD Institute for Integrative Cancer Care
International Editor
Jacob Shoham, MD, PhD Bar-Ilan University, Ramat-Gan, Israel
Assistant Editors
Advisory Board Members
James S. Gordon, MD Center for Mind-Body Medicine
William J.M. Hrushesky, MD Dorn Veterans Affairs Medical Center
Wayne Jonas, MD Uniformed Services University of the Health Sciences
John Pezzuto, PhD Purdue University, USA
Azra Raza, MD Rush Presbyterian Hospital
Julia Rowland, PhD National Cancer Institute
Leslie Sandlow, MD University of Illinois at Chicago, USA
Stephen P. Tomasovic, PhD MD Anderson Cancer Center
Debu Tripathy, MD University of Southern California, USA
Nicholas Vogelzang, MD Nevada Cancer Institute
Editorial Board
Dave Blask, PhD, MD Bassett Research Institute
Phyllis Bowen, PhD University of Illinois at Chicago, USA
D. Barry Boyd, MD Integrative Oncology
Terence Bugno, MD Northern Illinois Center for Cancer Care
Raymond Chang, MD Institute of East-West Medicine
Lorenzo Cohen, PhD M.D. Anderson Cancer Center
Geoffrey Cordell, PhD University of Illinois at Chicago, USA
Michael de la Torre, MD Block Center for Integrative Cancer Treatment
Jeremy Geffen, MD Geffen Visions International
Steven Greer, MD St. Raphael's Hospice
Michael J. Hawkins, MD Washington Cancer Institute
Arika Hirsch, MD Associated Radiologists, Ltd
Judith Jacobson, MD Columbia University College of Physicians and Surgeons
John Knaus, DO St. Francis Hospital
Lawrence Kushi, ScD Columbia University Teachers College
Brian Lawenda 21st Century Oncology
Robert A. Nagourney, MD Rational Therapeutics Inc
Alfred I. Neugut, MD, PhD Columbia University Presbyterian Hospital
Mark Renneker, MD University of California, San Francisco, USA
Stephen M. Sagar, MD Hamilton Regional Cancer Centre
Carole M. Schneider, PhD University of Northern Colorado
Victor S. Sierpina University of Texas
Lydia Temoshok, PhD Maryland Biotechnology Center
Jeanne Wallace Nutritional Solutions
Editorial Consultants
Mark Blumenthal Executive Director, American Botanical Council
Michael Broffman, LAc Pine Street Clinic
Gar Hildenbrand Gerson Research Organization
Mark Myers, RD Institute for Integrative Cancer Care
Donald R. Yance Jr., CN, MH, AHG Centre for Natural Healing
  • AgBiotech News and Information
  • AgBiotechNet
  • CAB Abstracts (Index Veterinarius, Veterinary Bulletin)
  • CAB Health
  • CABI: Abstracts on Hygiene and Communicable Diseases
  • CABI: CAB Abstracts
  • CABI: Forest Products Abstracts
  • CABI: Forestry Abstracts
  • CABI: Global Health
  • CABI: Nutrition Abstracts and Reviews Series A
  • CABI: Review of Aromatic and Medicinal Plants
  • CABI: Tropical Diseases Bulletin
  • CINAHL
  • Chemical Abstracts Service (CAS)
  • EMBASE
  • Elsevier BIOBASE/Current Awareness in Biological Sciences
  • Horticultural Science Abstracts
  • Index Medicus
  • InfoTrac (full text)
  • MEDLINE
  • Postharvest News and Information
  • ProQuest: International Pharmaceutical Abstracts
  • Rural Development Abstracts
  • Science Citation Index Expanded (Web of Science)
  • Scopus
  • Soybean Abstracts
  • Please review the full Integrative Cancer Therapies author guidelines before submitting a manuscript to the journal.

    ICT accepts Research Articles, Review Papers, Case Reports, Educational Articles, Letters to the Editor and Commentaries. Please review the author guidelines for more information on each paper type.

    This Journal is a member of the Committee on Publication Ethics.

    This Journal recommends that authors follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals formulated by the International Committee of Medical Journal Editors (ICMJE)

    Please read the guidelines below then visit the Journal’s submission site https://mc.manuscriptcentral.com/ict to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.

    There is no charge for submitting a paper to ICT. For each accepted manuscript, you will be charged a one-time Article Processing Charge (APC). This fee covers the cost of publication and ensures that your article will be freely open to all worldwide.
    An introductory Article Processing Charge (APC) of $900, discounted from the full rate of $1800, is available for a limited time.

    Only manuscripts of sufficient quality that meet the aims and scope of Integrative Cancer Therapies will be reviewed.

    As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

    Before publication SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. Integrative Cancer Therapies publishes manuscripts under Creative Commons licenses. The standard Integrative Cancer Therapies license is Creative Commons by Attribution Non-Commercial (CC BY-NC 3.0), which allows others to re-use the work without permission as long as the work is properly referenced and the use is non-commercial. For more information, you are advised to visit SAGE's OA licenses page.

    Any correspondence, queries or additional requests for information on the Manuscript Submission process should be sent to the Editorial Office as follows:


    Keith I. Block, M.D.,
    Editor-in-Chief, Integrative Cancer Therapies
    Block Center for Integrative Cancer Treatment
    5230 Old Orchard Road
    Skokie IL 60077
    Telephone: 847-492-3040

    For inquiries about the status of manuscripts after submission, please contact:

    Charlotte Gyllenhaal, Ph.D.,
    Managing Editor, Integrative Cancer Therapies
    Block Center for Integrative Cancer Treatment
    5230 Old Orchard Road
    Skokie IL 60077
    Telephone: 847-492-3040
    E-mail:
    cgyllenhaal@blockmedical.com

    To subscribe to Integrative Cancer Therapies, please visit http://ict.sagepub.com.

    Please select a format:

    Individual Subscription, Print Only


    Institutional Subscription, Print Only


    Individual, Single Print Issue


    Institutional, Single Print Issue